2. What do you mean by disc
edema?
Means swelling of the optic disc.
It includes all causes of active or passive edematous swelling
of the optic disc other than the causes of papilledema
3. You can notice,
Disc hyperemia
Blurred disc margins
Nerve fiber layer swelling
Disc elevation
Tortuous vessels
4. Is it a true edema or not,
Causes for pseudodisc edema,
1) Optic nerve head drusen
2) Myelinated nerve fibres
3) Morning glory syndrome
4) Tilted disc
5) Small hypermetropic disc
6) Optic disc hypoplasia
7) Bergmeister’s papilla
5. Optic disc drusen
Composed of hyaline like calcific material within the substance of the optic
nerve head.
Present in 0.3% of population
Are often bilateral
Associations include,
Retinitis pigmentosa
Angioid streak
Alagille syndrome
Complications-usually rare,
include CNV,CRVO,CRAO
Imaging,
FA-shows progressive hyperfluorescence due to staining but absence of
leakage
US-most reliable method because of its ability to detect calcific deposits that
show high acoustic reflectivity
7. Myelinated nerve fibres
In normal eyes ,optic nerve myelination stops at the
cribriform plate.
In eyes with myelinated nerve fibres the ganglion cells retain
a myelin sheath.
Most often unilateral.
Ocular associations include high myopia,anisometropia
and amblyopia.
Systemic associations include NF1 and Gorlin syndrome
9. Morning glory syndrome
Very rare usually unilateral sporadic condition.
Signs,
VA-may be normal or impaired to a variable extent.
Large disc with funnel shaped excavation surrounded by an
annulus of chorioretinal disturbance.
Blood vessels emerge from the rim of the excavation in a radial
pattern like the spokes of a wheel.
Complications,
Serous retinal detachment develops in about 30% of cases.
CNV is less common and develop adjecent to the lesion
10.
11. Systemic associations,
Frontonasal dysplasia-mid facial anomalies consisting of
hypertelorism, flat nasal bridge and occasionally a mid line
notch in the upper lip and a midline cleft in the soft palate.
Midline brain malformations- absent corpus callosum,
hypoplastic cerebellar vermis, small optic chiasm, malformed
occipital lobe, pituitary deficiency.
NF2 -less common.
PHASE syndrome-posterior fossa brain malformations,
large facial hemangiomas and cardiovascular anomalies.
13. Tilted disc
Is common and usually bilateral anomaly caused by an oblique
entry of the optic nerve into the globe.
Signs,
Small oval or D shaped disc
Disc margin is indistinct where the retinal nerve fibres are elevated.
Associated finding includes inferonasal chorioretinal thining and
myopic astigmatic refractive error.
Perimetry-
superotemporal defects that do not respect vertical midline.
Complications-
uncommon, include CNV and sensory macular detachment.
14.
15. Optic nerve hypoplasia
Unilateral or bilateral
Characterized by a diminished number of nerve fibres.
Commonly involving the midline structures of the brain.
Predisposition,
Agents taken by mother during gestation.
LSD, quinine,anticonvulsants,excess alcohol
Superior segmental hypoplasia may be associated with
maternal diabetes.
16. presentation
Severe bilateral cases present with blindness in early infancy.
Less severe bilateral involvement may cause minor minor visual defects
or squint at any time in childhood.
Unilateral cases usually present with squint.
Signs,
VA may be normal or impaired to a variable degree, even to NPL.
Double ring sign-small gray disc surrounded by a yellow halo of
hypopigmentation caused by concentric chorioretinal atrophy.
Distance from the fovea to the temporal border of the optic disc often equals
or exceeds 3 times the disc diameter
Retinal vessels are normal in caliber but tortuous
17.
18. Other features
Depends on the severity
Includes astigmatism,field defect , dyschromatopsia , APD,
foveal hypoplasia, aniridia, microphthalmos, strabismus,
nystagmus
Systemic associations,
Wide variety of midline developmental brain defects-most
common De Morsier syndrome(septo-optic dysplasia)
Characterized by absence of septum pellucidum agenesis of
corpus callosum, hypopituitarism
Bilateral optic nerve hypoplasia may be a marker for
potential endocrine dysfunction.
19. Causes of true disc edema
Inflammatory-
papillitis, neuroretinitis, papillophlebitis and uveitis
Ocular hypotony
due to any cause
Vascular
CRVO, diabetic papillopathy , uremia, AION
Orbital causes
tumors,Graves orbitopathy, orbital cellulitis
Infiltrative conditions
leukaemias,lymphomas
20. papilloedema
Is hydrostatic non inflammatory edema of optic disc due to
raised intracranial pressure.
Is almost always bilateral although it may be asymetrical.
Etiology-
Intracranial causes,
congenital-
Aqueductal stenosis
craniosynostosis
21. Intracranial space occupying lesions
Brain tumors-commonly tumors arising in posterior fossa-
cerebellum,midbrain,parieto-ocipital region which obstruct
aqueduct of sylvius.
Abscess,tuberculoma,gumma,subdural
hematoma,aneurysms,hydrocephalus
Intracranial infections
meningitis,encephalitis
IC h’age
SAH,SDH
22. Obstruction to CSF absorption by arachnoid villi
Direct blockage of villi by blood and protein
Cavernous sinus thrombosis
Damaged arachnoid villi
Hypersecretion of CSF
Tumors of spinal cord
Idiopathic intracranial hypertension
pseudotumor cerebri,due to drugs like
tetracycline,vit.A,N.acid,contraceptives, corticosteroids
24. Pathogenesis(hayreh’s theory)
Increased IC pressure,malignant hypertension and orbital
lesions
Increased in tissue pressure in retrolaminar region
Alteration in pressure gradient across lamina cribrosa
Stasis of axoplasm in prelaminar region of optic disc
Axonal swelling in prelaminar region
Extracellular edema
papilledema
25. Clinical features
Usually bilateral(in case of raised ICP) but may be
unilateral(in case oforbital or ocular causes)
General features,
Features of raised ICP
Headache,worsen on coughing,sneezing or straining
Projectile vomiting(without nausea)
Diplopia
Focal neurological deficit with changes in level of
consciousness.
26. Optic neuritis
Is an inflamatory,infective and demyelinating process
affecting the optic nerve.
Types of ON,
1) Ophthalmoscopical classification
2) Aetiological classification
27. Triad of symptoms
Visual loss
sudden,progressive and profound visual loss varying in severity
Eye pain
dull eye pain aggravated by ocular movement,esp.upward and
downward movement
Dyschromatopsia
28. Other symptoms
Impaired colour vision
Visual obscuration in bright light(typical feature)
Movement phosphenes and sound induced phosphenes
Uhthoff’s symptoms-episodic transient obscuration of vision
on exertion and increase in body temperature which recovers
at rest.
Pulfrich phenomenon-impaired depth perception for moving
objects
29. Signs of optic nerve
dysfunctions
Decreased visual acuity and colour vision
Diminished light brightness and contrast sensitivity
Marcus Gunn pupil
Visual field defects
30. pathogenesis
Inflammatory changes in the optic nerve
or/and in the sheath(perineuritis)
Infiltration by T lymphocytes and plasma
cells
Loss of myelin sheath
Degenerative changes and reactionary
gliosis
31. Ophthalmoscopical classification
1) Retrobulbar neuritis
Normal optic nerve head
Involve retrobulbar part of optic nerve
Common in adults
2) Papillitis
Hyperemia and edema of optic disc
Associated with peripapillary flame-shaped haemorrhages usually unilateral.
Common in children and young adults
3) Neuroretinitis
Characterized by papillitis in association with inflammation of RNFL and
macular star figure
Occur in children and more often bilateral
Mostly infectious in etiology.
32. Aetiological classification
Demyelinating-most common
Isolated
Multiple sclerosis
Neuromyelitis optica of Devic’s
Diffuse paraxial encephalitis of schilder
Parainfectious
may follow a viral infection or immunization
Infectious
o Local-endophthalmitis,orbital cellulitis, sinusitis, meningitis, retinochoroiditis
o systemic,
Viral-influenza,measles,mumps,chickenpox,herpes zoster,EBV,CMV
Bacterial-TB,syphilis,cat scratch disease,lyme disease
Fungal-cryptococosis,histoplasmosis
Protozoal-toxocara,toxoplasma,malaria,pneumocystic carinii
Parasitic-cysticercosis
34. Fundus picture
Retrobulbar neuritis
Normal fundus
-site of involvement is behind the eyeball.
Temporal disc pallor
-due to involvement of papillomacular bundle
Slight distention of veins and attenuation of arteries(if lesion is
near lamina cribrosa)
35. papillitis
Hyperemic disc
Blurring of disk margins
Disc oedema
Congested and tortuous retinal veins
Flame shaped haemorrhages and soft exudates on disc and
retina
Cloudy vitrious with fine opacities
Inflammatory cells in vitreous,obliteration of physiological cup
with organised fibrous tissue
Perivascular sheathing
39. Presenting Symptoms of MS
Symptom Approximate Prevalence
Weakness in one or more
limbs
40-50%
Sensory loss/paresthesias 40-45%
Visual loss 16-36%
Gait disturbance/ataxia 5-15%
Diplopia 7-15%
Dizziness/vertigo 5%
Pain 3%
Sensory in face 3%
53. Neuromyelitis optica (NMO)
Acute/subacute demyelination, necrosis of optic
nerves, spinal cord
Often preceded by viral illness, associated with
systemic autoimmune disease
Partial responses to steroids, other
immunosuppressants
54. Key clinical features
Optic neuritis
Acute/subacute
neuropathic visual loss
Typically painful
Mild, if any, disc edema
Myelitis
Acute/subacute weakness,
numbness
Bowel/bladder problems
L’hermitte’s sign
55. The broadening spectrum of NMO
‘Textbook’ form’
Monophasic
Simultaneous ON and SC
disease
Bilateral ON involvement
No disease outside SC, ONs
No brain MRI lesions
Current description
>70% recurrent
ON and SC attacks may be years
apart
ON disease may be unilateral
Brain disease occurs (ca. 10%)
Brain MRI changes may
occasionally resemble multiple
sclerosis
ON – optic nerve
SC – spinal cord
56. NMO – disease or syndrome?
Differential diagnosis
a) Multiple sclerosis
b) Acute disseminated encephalomyelitis (ADEM)
c) Lupus
d) Sjogren’s syndrome
e) Parainfectious
57. How does NMO compare with MS?
Similarities
- Female predilection
- Age of onset
- Relapse rate
Differences
- Geography
- Brain symptoms
- Prognosis
- MRI appearance
- Cerebrospinal fluid
findings
- Response to treatment
58. Ancillary tests in NMO
MRI
Elongated, expansile, enhancing spinal cord lesions
Brain MRI usually normal; occasional multiple-sclerosis-like
plaques or confluent/symmetrical lesions
CSF
>50 white blood cells/mm3 or >5 polymorphonuclear
leucocytes/mm3 common
Oligoclonal bands, ↑IgG synthesis less common
59. ‘The NMO antibody’
IgG autoantibody localizes to glia at blood-brain-barrier
Binds to aquaporin-4, the main water channel in the
central nervous system
About 90% specific, 75% sensitive for NMO
Often + in brain MRI- negative relapsing myelitis/optic
neuritis
Available commercially
60. The epidemiology of MS and NMO differs
in Japan and the West
Lower prevalence of MS in Japan
Higher ratio of classic, monophasic
NMO to MS, likely true throughout Asia
More Japanese ‘MS’ patients present with
bilateral optic neuropathy and severe ON
or SC disease (ca. 25%)
Up to 60% of ‘Asian optospinal’ MS may
be + for NMO-IgG, implying that this
condition represents recurrent NMO
61. Laotian woman
Age 47-52: 4 bouts
unilateral optic
neuritis
Age 54: transverse
myelitis
Exam: no light
perception OD,
20/20 OS, spastic
paraparesis
NMO-IgG positive
62. NMO: the latest criteria
• History of optic neuritis
• History of acute myelitis
• Two of three of:
MRI spinal cord lesion > 3 segments
+ NMO-IgG antibody
Brain MRI not consistent with multiple sclerosis
63. Who will relapse?
Older patients with more common, sequential optic
neuritis/myelopathic disease
Less severe disease at onset
High-titer + NMO-IgG antibodies
Step-wise progression portends worse prognosis than
monophasic disease
64. Treatment for NMO*
Relapses/acute disease
IV methylprednisolone 1000 mg/day, 3-5 days
Plasmapheresis
Prevention / stabilization
Consensus: ABCR drugs not helpful
Azathioprine 2.5-3 mg/kg/day
Concurrent prednisone 1 mg/kg/day, tapering slowly
after azathioprine takes effect
Mycophenolate mofetil, Mitoxantrone, Rituximab, IVIg,
Plasmapheresis possible second liners
* No class I or II data
65. Optic Neuritis Clinical Treatment
Trial
Initiated in 1988, enrolled 457
patients, utilizing 15 clinical centers
throughout U.S.
Patients randomized to one of three
regiments
A) Oral Prednisone (1mg/kg/day for
14 days
B) IV Methylprednisolone (250mg
every 6 hours for 3 days,
followed by Oral Prednisone 1
mg/kg for 11 days
C) Oral Placebo for 14 days
Eligible Patients
a) 18 to 46 years of age
b) Acute unilateral optic neuritis with
visual symptoms 8 days or less
c) +RAPD and Field Defect in
affected eye
d) No previous episodes of Optic
Neuritis in affected eye
e) No previous corticosteroid
treatment for optic neuritis or M.S.
f) No systemic dx other than M.S.
that could cause Optic Neuritis
66. Key Findings of ONTT
1. Corticosteroid Therapy for Optic Neuritis
has no long term beneficial effect on vision
2. Methylprednisolone regiment sped
recovery by 1-2 weeks
3. Patients receiving Oral Prednisone
regiment didn’t experience any benefit, in
fact there was a recurrence rate double of
the other groups
4. Patients with MRI scans demonstrating 2
or more white matter lesions, treated with
IV steroids experience a 2 year protective
effect (36% untreated vs 16%) that
disappeared after year 3
67. Key Findings of ONTT
Periventricular white matter lesions demonstrating
demyelination most critical for assessing risk of developing
M.S.
Zero Lesions: 25% chance of developing M.S. within 5 years
One Lesion or more: 72% chance of developing M.S. in 15 year
period
Lower risk of developing M.S. associated:
a) male sex
b) optic disc swelling
c) atypical features of optic neuritis (absence of pain, NLP
vision, peripapillary hemorrhages, retinal exudates)
68. Literature Review
Control All M.S. Eyes M.S. without
Optic Neuritis
M.S. with hx
of Optic
Neuritis
Low Contrast
(2.5%) # of
letters correct
25 +/- 7 (61
eyes)
16 +/- 10 (239
eyes)
18 +/- 10 (150
eyes)
11 +/- 11 (87
eyes)
Spectralis
Domain OCT
(peripapillary
RNFL
thickness μm)
92.9 +/- 10
(61 eyes)
84.3 +/- 12.8
(239 eyes)
87.6 +/-11.1
(150 eyes)
78.4 +/- 13.6
(87 eyes)
• Study found significant relationship between well validated
National Eye Institute: Vision Related Quality of Life Survey
Score and the following:
• Low Contrast Visual Acuity Score
• RNFL
• Clinical Trials utilizing OCT to evaluate the effectiveness of
immunomodulatory therapy